Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 170 entries
View as:

Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT01803087 Org: User:
Start: 02/29/12 End: 10/31/12 Due: 10/31/13

Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00640484 Org: User:
Start: 04/30/08 End: 10/31/08 Due: 10/31/09

Clinical Study to Investigate the Pharmacokinetics, Safety and Tolerability Following Single Administration of CHF6001 in Subjects With Mild, Moderate and Severe Liver Impairment in Comparison With Matched Healthy Control Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05373953 Org: User:
Start: 05/05/22 End: 11/25/22 Due: 11/25/23

Efficacy of Nebulized Beclomethasone Dipropionate (BDP) in the Treatment of Moderate Croup

Phase: N/A Priority: Normal
NCT ID: NCT00938353 Org: User:
Start: 04/30/10 End: 09/30/10 Due: 09/30/11

Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

Phase: N/A Priority: Normal
NCT ID: NCT01343745 Org: User:
Start: 02/29/08 End: 08/31/08 Due: 08/31/09

Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®

Phase: N/A Priority: Normal
NCT ID: NCT05898984 Org: User:
Start: 04/24/23 End: 07/14/23 Due: 07/14/24

Expanded Access to Velmanase Alfa

Phase: N/A Priority: Normal
NCT ID: NCT04959240 Org: User:
Start: - End: - Due: -

Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient

Phase: N/A Priority: Normal
NCT ID: NCT03888131 Org: User:
Start: 07/30/18 End: 05/06/22 Due: 05/06/23

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease

Phase: N/A Priority: Normal
NCT ID: NCT06328608 Org: User:
Start: 02/28/25 End: 03/31/28 Due: 03/31/29

Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe COPD

Phase: N/A Priority: Normal
NCT ID: NCT03004417 Org: User:
Start: 10/31/16 End: 12/28/17 Due: 12/28/18

Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase

Phase: N/A Priority: Normal
NCT ID: NCT01602393 Org: User:
Start: 05/31/12 End: 10/31/13 Due: 10/31/14

A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR)

Phase: N/A Priority: Normal
NCT ID: NCT01351792 Org: User:
Start: 09/30/11 End: 11/30/12 Due: 11/30/13

Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT01468272 Org: User:
Start: 11/30/11 End: 08/31/12 Due: 08/31/13

Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)

Phase: N/A Priority: Normal
NCT ID: NCT01703052 Org: User:
Start: 07/31/11 End: 05/31/12 Due: 05/31/13

Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00476268 Org: User:
Start: 02/29/04 End: 01/31/05 Due: 01/31/06

Study to Assess the Effect of the New HFA-152a Propellant on Mucociliary Clearance

Phase: N/A Priority: Normal
NCT ID: NCT05875025 Org: User:
Start: 06/26/23 End: 09/08/23 Due: 09/08/24

Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000

Phase: N/A Priority: Normal
NCT ID: NCT01651455 Org: User:
Start: 09/30/12 End: 06/30/13 Due: 06/30/14

A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)

Phase: N/A Priority: Normal
NCT ID: NCT02452476 Org: User:
Start: 01/21/16 End: 05/24/18 Due: 05/24/19

CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD

Phase: N/A Priority: Normal
NCT ID: NCT05097014 Org: User:
Start: 10/28/21 End: 02/24/23 Due: 02/24/24

Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI

Phase: N/A Priority: Normal
NCT ID: NCT01349257 Org: User:
Start: 05/31/11 End: 06/30/11 Due: 06/30/12

Pilot Pharmacokinetic Clenil Study With AeroChamber Plus™ or Volumatic™ Spacer Devices

Phase: N/A Priority: Normal
NCT ID: NCT01370031 Org: User:
Start: 04/30/11 End: 06/30/11 Due: 06/30/12

Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis

Phase: N/A Priority: Normal
NCT ID: NCT02998879 Org: User:
Start: 12/31/16 End: 07/31/20 Due: 07/31/21

A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®

Phase: N/A Priority: Normal
NCT ID: NCT01111383 Org: User:
Start: 09/30/09 End: 05/31/11 Due: 05/31/12

Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00777595 Org: User:
Start: 10/31/08 End: 12/31/08 Due: 12/31/09

Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3

Phase: N/A Priority: Normal
NCT ID: NCT06184503 Org: User:
Start: 02/19/25 End: 09/30/29 Due: 09/30/30